437998-34-0

Basic information

• Product Name: BenzaMide, 2-aMino-3-broMo-
• Synonyms: BenzaMide, 2-aMino-3-broMo-;2-Amino-3-bromobenzamid
• CAS NO: 437998-34-0
• Molecular Formula: C₇H₇BrN₂O
• Molecular Weight: 215.04728
• Mol File: 437998-34-0.mol
• Article Data: 5

Chemical Properties

• Melting Point: 249-250 °C
• Boiling Point: 292℃
• Flash Point: 131℃
• Appearance: /
• Density: 1.698
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• PKA: 15.15±0.50(Predicted)
• CAS DataBase Reference: BenzaMide, 2-aMino-3-broMo-(CAS DataBase Reference)
• NIST Chemistry Reference: BenzaMide, 2-aMino-3-broMo-(437998-34-0)
• EPA Substance Registry System: BenzaMide, 2-aMino-3-broMo-(437998-34-0)

Safety Data

• Hazardous Substances Data: 437998-34-0(Hazardous Substances Data)

Usage

General Description

Benzamide, 2-amino-3-bromo- is a chemical compound with the molecular formula C7H6BrNO. It's often used in organic synthesis and it belongs to the chemical class of benzamides. Benzamides are organic compounds containing a carboxamido substituent attached to a benzene ring. The 2-amino-3-bromo- derivative means that an amino group (-NH2) is attached at the second carbon position and a bromine atom at the third. The precise handling, storage, and disposal instructions, as well as safety precautions for this compound, should be followed as recommended in its Safety Data Sheet.

Upstream product

• 20776-51-6 2-amino-3-bromo benzoic acid 
• 331646-98-1 8-bromo-1H-benzo[d][1,3]oxazine-2,4-dione 
• 20780-74-9 7-bromoisatin 

Relevant articles and documents

Oxidative ring-opening of isatins for the synthesis of 2-aminobenzamides and 2-aminobenzoates

An efficient and practical isatin-based oxidative domino protocol has been developed for the facile synthesis of 2-aminobenzamides and 2-aminobenzoates. The robust nature of this reaction system is reflected by accessible starting materials, room temperature and high-yield gram-scale synthesis.

HETEROCYCLIC COMPOUNDS AS ANTIBIOTIC POTENTIATORS

The invention relates to heterocyclic compounds and their use as antibiotics and/or as antibiotic potentiators. The compounds may act as colistin potentiators and SOS inhibitors.

QUINAZOLINE COMPOUNDS AND METHODS OF USE THEREOF

Provided herein are quinazoline compounds for treatment of JAK kinase mediated diseases, including JAK2 kinase-, JAK3 kinase- or TYK2 kinase-mediated diseases. Also provided are pharmaceutical compositions comprising the compounds and methods of using the compounds and compositions.